|
|||||
|
|
High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: A population-based analysis |
|
| Authors: | T. Chandrasekar Z. Klaassen H. Goldberg R. Sayyid G. Kulkarni N. Fleshner |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |